XVIE

· Restore Biologics Holdings, Inc. dba Xtressé

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XVIE, covering 2025-11-06 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: XVIE to Treat Androgenetic Alopecia (AGA) [Phase 1, Phase 2]